Skip to search formSkip to main contentSkip to account menu

Nadroparin

Known as: Nadroparin Calcium, Nadroparin [Chemical/Ingredient], Nadroparine 
A low molecular weight heparin (LMWH) composed of a heterogeneous mixture of sulfated polysaccharide glycosaminoglycan chains obtained by… 
National Institutes of Health

Related topics

Related topics

14 relations

Broader (2)

AnticoagulantsFibrinolytic Agents

Narrower (3)

CY 216FraxiparinLMF CY-216
In BloodProcess of secretionagonistsanalogs & derivatives

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Influence of chemical and structural features of low molecular weight heparins (LMWHs) on skin penetration.
2012
2012
The mechanisms of nadroparin‐mediated inhibition of proliferation of two human lung cancer cell lines
Clinical data suggest that heparin treatment improves survival of lung cancer patients, but the mechanisms involved are not fully… 
2010
2010
Thromboprophylaxis during chemotherapy in patients with advanced cancer.
2005
2005
Iatrogenic calcinosis cutis following nadroparin injection
Accumulation of calcium in the skin is usually classified as a group of disorders referred to as calcinosis cutis. We report the… 
2002
2002
Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of low molecular weight heparin. Gynecological ward retrospective analysis.
Highly Cited
2002
Highly Cited
2002
Adverse Effect of Heparin on Antithrombin Action during Endotoxemia: Microhemodynamic and Cellular Mechanisms
Summary A recent clinical sepsis trial reported a significant reduction in 90-day mortality by antithrombin (AT) exclusively in… 
2000
2000
Local delivery of nadroparin for the prevention of neointimal hyperplasia following stent implantation: results of the IMPRESS trial. A multicentre, randomized, clinical, angiographic and…
BACKGROUND We hypothesized that intramural delivery of nadroparin, a low molecular weight heparin, would prevent in-stent… 
1997
1997
Enteroaggregative Escherichia coli in infant feeding bottles
1996
1996
low molecular weight heparin, nadroparin (Fraxiparine), inhibits thrombin‐induced platelet shape change and does not enhance spontaneous platelet aggregation
Therapeutic concentrations, added in vitro, of a low molecular weight heparin (LMWH), nadroparin (Fraxiparine), inhibit thrombin… 
1995
1995
The haemorrhagic effect of low molecular weight heparins, dermatan sulphate and hirudin.
In a randomized, blind study the primary effect on haemostasis after intravenous administration of dermatan sulphate (DS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)